H2020-JTI-IMI2-2018-14-two-stage
H2020-JTI-IMI2-2018-14-two-stage
- Programme
- H2020
- Funded projects (dataset)
- 4
- EU contribution (sum)
- €82,310,189
- Portal deadline
- —
Leading topic in historical projects: IMI2-2018-14-01
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- FPS1 coordinated
- OWKIN1 coordinated
- STICHTING AMSTERDAM UMC1 coordinated
- UMC UTRECHT1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- JANSSEN PHARMACEUTICA NV3 topic projects
- NOVARTIS3 topic projects
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN2 topic projects
- ASTRAZENECA AB2 topic projects
- BAYER AKTIENGESELLSCHAFT2 topic projects
- ROCHE2 topic projects
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED2 topic projects
- KU Leuven2 topic projects
- PFIZER2 topic projects
- TAKEDA DEVELOPMENT CENTRE EUROPE LTD2 topic projects
- TPIZ2 topic projects
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- JANSSEN PHARMACEUTICA NV · NOVARTIS4 shared
BE ↔ CH
- JANSSEN PHARMACEUTICA NV · ASTRAZENECA AB3 shared
BE ↔ SE
- 3 shared
- 3 shared
- JANSSEN PHARMACEUTICA NV · TPIZ3 shared
BE ↔ CH
- BAYER AKTIENGESELLSCHAFT · NOVARTIS3 shared
DE ↔ CH
- NOVARTIS · ASTRAZENECA AB3 shared
CH ↔ SE
- 3 shared
- 3 shared
- 3 shared
- TAKEDA DEVELOPMENT CENTRE EUROPE LTD · TPIZ3 shared
UK ↔ CH
- JANSSEN PHARMACEUTICA NV · PFIZER3 shared
BE ↔ UK
- 3 shared
- 3 shared
- 2 shared
- 2 shared
- JANSSEN PHARMACEUTICA NV · BII GMBH2 shared
BE ↔ DE
- JANSSEN PHARMACEUTICA NV · ROCHE2 shared
BE ↔ CH
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 41.25
- Median orgs / project
- 30.5
- Min / max orgs
- 17 – 87
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- United Kingdom29
- Germany21
- Spain19
- Belgium18
- Netherlands15
- France15
- Switzerland14
- Sweden9
- Italy9
- Denmark3
- United States3
- Norway2
- Ireland1
- Greece1
- Austria1
- Hungary1
- Poland1
- Portugal1
Organization types
- company29 orgs · 49 rows
- university43 orgs · 47 rows
- research_institute25 orgs · 27 rows
- sme17 orgs · 17 rows
- other14 orgs · 15 rows
- public_body10 orgs · 10 rows
Topics in funded projects
- IMI2-2018-14-01IMI2-2018-14-01· 1 projects
- IMI2-2018-14-02IMI2-2018-14-02· 1 projects
- IMI2-2018-14-03IMI2-2018-14-03· 1 projects
- IMI2-2018-14-04IMI2-2018-14-04· 1 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| 3TR Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions | H2020 | €40,273,192 |
| Trials@Home Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials | H2020 | €19,036,998 |
| Immune-Image Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies | H2020 | €15,000,000 |
| MELLODDY MachinE Learning Ledger Orchestration for Drug DiscoverY | H2020 | €8,000,000 |